mitoxantrone has been researched along with Kaposi Sarcoma in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández, DE | 1 |
| Pellino, ML | 1 |
| RamÃrez, B | 1 |
| Kaplan, L | 1 |
| Volberding, PA | 1 |
2 other studies available for mitoxantrone and Kaposi Sarcoma
| Article | Year |
|---|---|
Acute myelocytic leukaemia associated with Kaposi's sarcoma in a patient without serum antibodies to human immunodeficiency virus type 1.
Topics: Adult; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; HIV Antibodies; HIV-1; Hum | 1996 |
Failure (and danger) of mitozantrone in AIDS-related Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Anthraquinones; Bone Marrow; Humans; Mitoxantrone; Sarcoma, Kapo | 1985 |